Lantern Pharma Announces Establishing an A.I. Center of Excellence in India to Industrialize the RADR® Platform and Accelerate Global Development Opportunities with BioPharma Companies [Yahoo! Finance]
Lantern Pharma Announces Establishing an A.I. Center of Excellence in India to Industrialize the RADR® Platform and Accelerate Global Development Opportunities with BioPharma Companies
New to The Street Show #710 Airs Tonight at 6:30 PM EST on Bloomberg Television [Yahoo! Finance]
Lantern Pharma (NASDAQ:LTRN) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Lantern Pharma Reports Additional Positive LP-184 Phase 1a Results Showing Durable Disease Control in Heavily Pre-Treated Advanced Cancer Patients as Company Advances Precision Oncology Program into Multiple Biomarker-Guided Phase 1b/2 Trials